In the News

Share
1740 News Items found
Patient Story
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as Doctor
Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Q&A
MSK physician scientist Piro Lito, MD, PhD
A Potential Advance Against RAS-Driven Cancers
Learn about insights that could lead to a new class of drugs against cancers caused by RAS mutations.
immunofluorescence image of colorectal cancer cells
Unlocking the Secrets of Cancer Metastasis: MSK Study Provides New Insights, Potential Therapeutic Opportunities
Metastasis remains the primary challenge to reducing cancer deaths worldwide. A new MSK study is providing unique insights that researchers say point to new therapeutic opportunities.
A bone marrow transplant patient at MSK Kids hugs Dr. Maria Cancio, who treated him for sickle cell disease
Sickle Cell Disease Treatment Combines Clinical Excellence and a Personal Connection
After a relapse of sickle cell disease, Armani Rodriguez and his family found new hope and a special bond with Dr. Maria Cancio at MSK Kids.
MSK's Justin Jee, MD, PhD, and Ed Reznik, PhD, are seen smiling.
New Insights Into How Obesity Influences Cancer Driver Mutations
Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.
Mushrooms growing on a mossy log on the forest floor
Do Mushroom Supplements Boost Immunity Against Cancer?
Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom supplements.
In the Lab
MSK physician-scientist Dr. Charles Sawyers
New Insights Show ASCL1’s Role in Neuroendocrine Prostate Cancer, an Aggressive and Treatment-Resistant Type
Read about a powerful research model developed by MSK researchers to learn how the most common type of prostate cancer changes into a deadly form.
Article
Close up of microscope viewer.
MSK Research Highlights, October 15, 2024
New MSK research identifies a gene mutation associated with resistance to breast cancer treatment; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the best radiation level for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.
Joan Massagué stands in front of his mineral collection
Beyond the Bench: Sloan Kettering Institute Director Joan Massagué
Along with their alluring beauty, minerals — like scientific ideas — open a window onto the history of the world, Dr. Massagué says.
Article
Woman smiling with Central Park in the background.
FDA Approves New Drug Combination for ER+, HER2- Breast Cancer
Learn how a three-drug treatment appears to be very effective for ER+, HER2- breast cancers.